Cita APA

Gotto, G., Drachenberg, D. E., Chin, J., Casey, R., Fradet, V., Sabbagh, R., . . . Feifer, A. (2020). Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Can Urol Assoc J.

Citación estilo Chicago

Gotto, Geoffrey, et al. "Real-world Evidence in Patient-reported Outcomes (PROs) of Metastatic Castrate-resistant Prostate Cancer (mCRPC) Patients Treated With Abiraterone Acetate + Prednisone (AA+P) Across Canada: Final Results of COSMiC." Can Urol Assoc J 2020.

Cita MLA

Gotto, Geoffrey, et al. "Real-world Evidence in Patient-reported Outcomes (PROs) of Metastatic Castrate-resistant Prostate Cancer (mCRPC) Patients Treated With Abiraterone Acetate + Prednisone (AA+P) Across Canada: Final Results of COSMiC." Can Urol Assoc J 2020.